Astrana Health, Inc.
ASTH
$29.56
-$1.82-5.80%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 102.04% | 71.26% | |||
| Total Other Revenue | 38.59% | -1.79% | |||
| Total Revenue | 38.96% | -1.55% | |||
| Cost of Revenue | 51.70% | -1.84% | |||
| Gross Profit | -31.31% | 0.04% | |||
| SG&A Expenses | 10.13% | 5.15% | |||
| Depreciation & Amortization | 11.87% | -2.38% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 47.57% | -1.30% | |||
| Operating Income | -97.47% | -5.46% | |||
| Income Before Tax | -107.07% | -15.94% | |||
| Income Tax Expenses | -24.89% | -21.93% | |||
| Earnings from Continuing Operations | -140.97% | -13.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 128.61% | -7.12% | |||
| Net Income | -143.19% | -16.05% | |||
| EBIT | -97.47% | -5.46% | |||
| EBITDA | -75.21% | -4.85% | |||
| EPS Basic | -144.44% | -16.17% | |||
| Normalized Basic EPS | -95.21% | -25.43% | |||
| EPS Diluted | -145.45% | -17.50% | |||
| Normalized Diluted EPS | -95.15% | -25.71% | |||
| Average Basic Shares Outstanding | -2.82% | 0.15% | |||
| Average Diluted Shares Outstanding | -3.91% | 0.51% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||